Health ❯ Healthcare ❯ Medical Research

Neurology

Alzheimer's Disease Dementia Parkinson's Disease Epilepsy Biomarkers Stroke Neurodegenerative Diseases Migraine Treatment Multiple Sclerosis Amyotrophic Lateral Sclerosis

3 ARTICLES

last mo.

FDA Clears PrecivityAD2 Blood Test for Symptomatic Adults Aged 40 and Up

The clearance expands clinical use of a mass‑spectrometry blood biomarker for younger patients, with likely effects on trial enrollment and more targeted care.

10 ARTICLES

last mo.

WHO Says Up to 45% of Dementia Risk Is Preventable as Blood Tests Promise Earlier Diagnosis

4 ARTICLES

2mo ago

Blood Test p‑tau217 Predicts Alzheimer Risk but Not Ready for Routine Screening

6 ARTICLES

2mo ago

Biogen's Tau Drug Cuts Brain Tau but Misses Dose‑Response Goal

3 ARTICLES

3mo ago

34‑circRNA Blood Signature Outperforms pTau217 in Detecting and Predicting Alzheimer’s

3 ARTICLES

3mo ago

Brockman Family Donates $110 Million to Houston Methodist, New Tower to Carry Their Name

5 ARTICLES

3mo ago

Copper Compound Restores Brain Clearance Pump and Cuts Alzheimer’s Proteins in Mice

3 ARTICLES

3mo ago

Glucosamine Linked to Faster Dementia Progression and Higher Death Risk, Study Finds

7 ARTICLES

4mo ago

Glucosamine Linked to Faster Progression and Higher Death Rates in Alzheimer’s Patients

16 ARTICLES

4mo ago

Blood Tests and New PET Tracer Reveal Early Alzheimer’s Signals in Some Middle‑Aged Adults

4 ARTICLES

4mo ago

Study Identifies Switch That Halts Post‑Stroke Repair, Prolongs Recovery in Mice

3 ARTICLES

5mo ago

Migraine CGRP Drugs Tied to Lower Glaucoma Risk in Neurology Study

3 ARTICLES

5mo ago

Mayo Clinic Study Finds Autism Far More Common in Children With Epilepsy

3 ARTICLES

5mo ago

Common Blood Test Marker Linked to Higher Future Dementia Risk, Large Study Finds

21 ARTICLES

5mo ago

Major Review Says New Alzheimer’s Antibodies Offer No Meaningful Benefit

9 ARTICLES

5mo ago

Germany Rules No Added Benefit for New Alzheimer Antibodies After Major Review Finds Little Effect

Neurology

FDA Clears PrecivityAD2 Blood Test for Symptomatic Adults Aged 40 and Up

Estrogen-Only Menopausal Therapy Linked to Fewer Alzheimer’s Markers on Autopsy

New Blood Biomarkers Differentiate Alzheimer’s Risk by Disease Stage

Donanemab Slows Alzheimer's Decline, New AAIC Data Show

Blood p‑tau217 Test Predicts Elevated 5‑ and 10‑Year Alzheimer’s Risk

WHO Says Up to 45% of Dementia Risk Is Preventable as Blood Tests Promise Earlier Diagnosis

Blood Test p‑tau217 Predicts Alzheimer Risk but Not Ready for Routine Screening

Biogen's Tau Drug Cuts Brain Tau but Misses Dose‑Response Goal

34‑circRNA Blood Signature Outperforms pTau217 in Detecting and Predicting Alzheimer’s

Brockman Family Donates $110 Million to Houston Methodist, New Tower to Carry Their Name

Never miss stories about

Neurology

Copper Compound Restores Brain Clearance Pump and Cuts Alzheimer’s Proteins in Mice

Glucosamine Linked to Faster Dementia Progression and Higher Death Risk, Study Finds

Glucosamine Linked to Faster Progression and Higher Death Rates in Alzheimer’s Patients

Blood Tests and New PET Tracer Reveal Early Alzheimer’s Signals in Some Middle‑Aged Adults

Study Identifies Switch That Halts Post‑Stroke Repair, Prolongs Recovery in Mice

Migraine CGRP Drugs Tied to Lower Glaucoma Risk in Neurology Study

Mayo Clinic Study Finds Autism Far More Common in Children With Epilepsy

Common Blood Test Marker Linked to Higher Future Dementia Risk, Large Study Finds

Major Review Says New Alzheimer’s Antibodies Offer No Meaningful Benefit

Germany Rules No Added Benefit for New Alzheimer Antibodies After Major Review Finds Little Effect

Never miss stories about

Neurology